[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":210500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-6500000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1600000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-5900000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-1500000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_3_Q3_USD":200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_1_Q3_USD":0.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-600000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-100000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-6500000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-1600000.0,"OtherAssetsNoncurrent_0_Q3_USD":109000000.0,"OtherAssetsCurrent_0_Q3_USD":76000000.0,"OperatingIncomeLoss_3_Q3_USD":386100000.0,"OperatingIncomeLoss_1_Q3_USD":228700000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"NonoperatingIncomeExpense_3_Q3_USD":67300000.0,"NonoperatingIncomeExpense_1_Q3_USD":-24300000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":31300000.0,"InvestmentIncomeInterest_1_Q3_USD":3800000.0,"InvestmentIncomeInterest_3_Q3_USD":12500000.0,"Liabilities_0_Q3_USD":1219200000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":5048900000.0,"LiabilitiesCurrent_0_Q3_USD":320000000.0,"OtherLiabilitiesCurrent_0_Q3_USD":26000000.0,"LongTermLineOfCredit_0_Q3_USD":800000000.0,"MarketableSecuritiesNoncurrent_0_Q3_USD":1508700000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":37300000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-291100000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":423600000.0,"NetIncomeLoss_1_Q3_USD":162700000.0,"NetIncomeLoss_3_Q3_USD":363600000.0,"MarketableSecuritiesCurrent_0_Q3_USD":1091900000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":99200000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-28000000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-23500000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":457200000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":4202800000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":444700000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1270300000.0,"ShareBasedCompensation_3_Q3_USD":93800000.0,"StockholdersEquity_0_Q3_USD":3829700000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":79200000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":2800000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":14000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":42300000.0,"TreasuryStockCommonShares_0_Q3_shares":26619216.0,"TreasuryStockCommonValue_0_Q3_USD":2579200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":47600000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":47100000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":5600000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":15900000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":1067900000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":71000000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":10600000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":1398400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":50200000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":726700000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":5600000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":1003500000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_3_Q3_USD":45100000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":0.0,"ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_3_Q3_USD":108900000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":42300000.0,"PreferredStockValue_0_Q3_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":44900000.0,"InventoryNet_0_Q3_USD":96700000.0,"InterestPaidNet_3_Q3_USD":12100000.0,"CommonStockSharesOutstanding_0_Q3_shares":45021497.0,"CommonStockSharesIssued_0_Q3_shares":71640713.0,"CommonStockSharesAuthorized_0_Q3_shares":245000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":169800000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":908500000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":908500000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":4000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":2621000000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q3_USD":1112300000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q3_USD":1109200000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":2616600000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":1100000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":5500000.0,"AssetsCurrent_0_Q3_USD":2385900000.0,"Assets_0_Q3_USD":5048900000.0,"AccountsReceivableNetCurrent_0_Q3_USD":212800000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":341200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-20100000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2225500000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":200000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":10600000.0,"CommonStockValue_0_Q3_USD":700000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12400000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":24600000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":93800000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":100000.0,"AssetImpairmentCharges_3_Q3_USD":18200000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":39500000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":161200000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":357700000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":27700000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":204400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":453400000.0,"IncomeTaxesPaidNet_3_Q3_USD":130100000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":41700000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":89800000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":22000000.0,"ImpairmentOfLongLivedAssetsHeldForUse_3_Q3_USD":18200000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":55400000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_3_Q3_USD":100300000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":2700000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":2300000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q3_USD":44700000.0,"InterestExpense_1_Q3_USD":4600000.0,"InterestExpense_3_Q3_USD":13900000.0,"IncreaseDecreaseInInventories_3_Q3_USD":7400000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":49500000.0,"GoodwillGross_0_Q3_USD":28000000.0,"GainOnSaleOfInvestments_3_Q3_USD":91900000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":87900000.0,"CostsAndExpenses_1_Q3_USD":216000000.0,"CostsAndExpenses_3_Q3_USD":884200000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":273900000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":37300000.0,"EarningsPerShareBasic_1_Q3_USD":3.62,"Goodwill_0_Q3_USD":28000000.0,"EarningsPerShareBasic_3_Q3_USD":8.12,"EarningsPerShareDiluted_3_Q3_USD":7.72,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.2,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":31300000.0,"EquityMethodInvestmentRealizedGainLossOnDisposal_3_Q3_USD":91900000.0,"EquitySecuritiesFvNi_0_Q3_USD":99400000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":5500000.0,"EarningsPerShareDiluted_1_Q3_USD":3.42,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":44800000.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211103"}]